A patent dispute over a potentially lifesaving artificial heart valve is prompting a scramble among doctors and hospitals to treat desperately ill elderly patients before a court injunction curtails sale of one of the devices Tuesday Late last week a federal judge issued an injunction barring Medtronic Inc from selling its new minimally invasive heart implant in the US The decision followed a  jury verdict that the device infringed a patent held by Medtronics chief competitor Edwards Lifesciences Corp